FK 506 rescue therapy for resistant rejection episodes in liver transplant recipients
D'Alessandro, A.M.; Kalayoglu, M.; Pirsch, J.D.; Corwith, C.; Knechtle, S.J.; Reed, A.; Belzer, F.O.
Transplantation Proceedings 23(6): 2987-2988
1991
ISSN/ISBN: 0041-1345 PMID: 1721335 Document Number: 371787
Document emailed within 1 workday
Related Documents
Homan van der Heide, J.J.; Bilo, H.J.; Donker, A.J.; Wilmink, J.M.; Sluiter, W.J.; Tegzess, A.M. 1992: The effects of dietary supplementation with fish oil on renal function and the course of early postoperative rejection episodes in cyclosporine-treated renal transplant recipients Transplantation 54(2): 257-263Tellis, V.A.; Matas, A.J.; Quinn, T.A.; Glicklich, D.; Weiss, R.J.; Soberman, R.J.; Veith, F.J. 1987: Antilymphoblast globulin treatment of steroid-resistant rejection in cyclosporine-immunosuppressed renal transplant recipients Transplantation Proceedings 19(1 Part 3): 1892
Herget, S.; Heemann, U.; Friedrich, J.; Kribben, A.; Wagner, K.; Philipp, T. 1996: Initial experience with tacrolimus rescue therapy in OKT3 resistant rejection Clinical Nephrology 45(5): 352-354
Nashan, B.; Schlitt, H.J.; Ringe, B.; Bunzendahl, H.; Wittekind, C.; Wonigeit, K.; Pichlmayr, R. 1991: Differential diagnosis of viral infections and acute rejection episodes in liver grafted patients by transplant aspiration cytology Transplantation Proceedings 23(1 Part 2): 1507-1508
Stiller, C.; Keown, P. 1990: Failure of 125I-tracer selective monoclonal antibody levels on a whole blood matrix to predict rejection or nephrotoxic episodes in renal transplant patients under anti-lymphocyte globulin and prednisone therapy Transplantation Proceedings 22(3): 1253-1254
Stratta, R.; Shaefer, M.; Markin, R.; Bradshaw, K.; Donovan, J.; Wood, R.; Langnas, A.; Reed, E.; Woods, G.; Zetterman, R. 1991: Ganciclovir therapy for viral disease in liver transplant recipients Transplantation Proceedings 23(3): 1968
Grant, D.; Rochon, J.; Levy, G. 1996: Comparison of the long-term tolerability, pharmacodynamics, and safety of Sandimmune and Neoral in liver transplant recipients. Ontario Liver Transplant Study Group Transplantation Proceedings 28(4): 2232-2233
Wiesner, R.H.; Porayko, M.K.; Wahlstrom, H.E.; Gores, G.J.; Kamath, P.S.; Hay, J.E.; Krom, R.A. 1993: Early cellular rejection treated with high-dose intravenous corticosteroid therapy is associated with a decrease in the incidence of steroid-resistant rejection and graft failure from rejection Transplantation Proceedings 25(2): 1791-1793
Troppmann, C.; Almond, P.S.; Payne, W.D.; Dunn, D.L.; Gores, P.F.; Gruessner, R.W.; Sutherland, D.E.; Matas, A.J.; Najarian, J.S. 1993: Does acute tubular necrosis affect renal transplant outcome? the impact of rejection episodes Transplantation Proceedings 25(1 Part 2): 905
Mezidi, M.; Belafia, F.; Nougaret, S.; Pageaux, G.P.; Conseil, M.; Panaro, F.; Boniface, G.; Morquin, D.; Jaber, S.; Jung, B. 2014: Interferon gamma in association with immunosuppressive drugs withdrawal and antifungal combination as a rescue therapy for cerebral invasive Aspergillosis in a liver transplant recipient Minerva Anestesiologica 80(12): 1359-1360
Hardinger, K.L.; Alford, K.; Murillo, D. 2009: Bortezomib for acute humoral rejection in two repeat transplant recipients Clinical Transplants 2009: 479-483
Russo, P.; Alpern, J.; Donner, R.; Davis, D.A. 1992: Monitoring rejection in heart transplant recipients: the Temple University experience Journal of Nuclear Biology and Medicine 36(2 Suppl): 52-55
Dimény, E.; Fellström, B.; Larsson, E.; Tufveson, G.; Lithell, H. 1992: Lipoprotein abnormalities in renal transplant recipients with chronic vascular rejection Transplantation Proceedings 24(1): 366
Reitz, B.A.; Gaudiani, V.A.; Hunt, S.A.; Wallwork, J.; Billingham, M.E.; Oyer, P.E.; Baumgartner, W.A.; Jamieson, S.W.; Stinson, E.B.; Shumway, N.E. 1983: Diagnosis and treatment of allograft rejection in heart-lung transplant recipients Journal of Thoracic and Cardiovascular Surgery 85(3): 354-361
Wong, W.; Lee, R-Ann.; Saidman, S.L.; Smith, R.Neal.; Zorn, E. 2009: Bortezomib in kidney transplant recipients with antibody mediated rejection: three case reports Clinical Transplants 2009: 401-405
Grinde, S.; Fagoaga, O.; Thorpe, R.; Wahlstrom, E.; Bailey, L.; Nehlsen-Cannarella, S. 1994: Evaluation of predictors of rejection and infection in cyclosporine-treated solid organ transplant recipients Transplantation Proceedings 26(5): 2738-2740
Kahan, B.D.; Julian, B.A.; Pescovitz, M.D.; Vanrenterghem, Y.; Neylan, J. 1999: Sirolimus reduces the incidence of acute rejection episodes despite lower cyclosporine doses in caucasian recipients of mismatched primary renal allografts: a phase II trial. Rapamune Study Group Transplantation 68(10): 1526-1532
Winkler, M.; Haller, G.; Oldhafer, K.; Bechstein, W.O.; Kattner, A.; Maibücher, A.; Färber, L.; Ringe, B.; Christians, U.; Neuhaus, P.; Pichlmayr, R. 1996: A new oral formulation of cyclosporine for early oral immunosuppressive therapy in liver transplant recipients Transplantation 62(8): 1063-1068
Palmer, J.; Slook, P. 1992: Successful use of Orthoclone OKT 3 for steroid-resistant acute rejection in pediatric renal allograft recipients Anna Journal 19(4): 375-377
Mohanakumar, T.; Hoshinaga, K.; Wood, N.L.; Szentpetery, S.; Lower, R.R. 1986: Enumeration of transferrin-receptor-expressing lymphocytes as a potential marker for rejection in human cardiac transplant recipients Transplantation 42(6): 691-694